NCT02604420View on ClinicalTrials.gov

Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions
Thrombotic MicroangiopathyDisorder Related to Bone Marrow Transplantation
Interventions
DRUG

eculizumab

Trial Locations (1)

10021

New York Presbyterian Hospital, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02604420 - Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants | Biotech Hunter | Biotech Hunter